Gts Securities LLC Iovance Biotherapeutics, Inc. Call Options Transaction History

Gts Securities LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 13, 2024	SELL	$7.28 - $11.9 $8,736 - $14,280	-1,200 Reduced 7.19%	15,500 $145,000
Q2 2024 Aug 14, 2024	SELL	$7.78 - $14.19 $45,902 - $83,721	-5,900 Reduced 26.11%	16,700 $133,000
Q1 2024 May 15, 2024	SELL	$7.59 - $17.47 $778,734 - $1.79 Million	-102,600 Reduced 81.95%	22,600 $334,000
Q4 2023 Feb 14, 2024	SELL	$3.3 - $8.89 $48,180 - $129,794	-14,600 Reduced 10.44%	125,200 $1.02 Million
Q3 2023 Nov 15, 2023	BUY	$4.44 - $8.79 $620,712 - $1.23 Million	139,800 New	139,800 $636,000

314

241M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.35B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

Stay updated on Gts Securities LLC with notifications on news.